KALA - Kala Pharmaceuticals EPS misses by $0.09 misses on revenue February, 25 2021 07:08 AM Kala Pharmaceuticals Inc. Kala Pharmaceuticals (KALA): Q4 GAAP EPS of -$0.55 misses by $0.09.Revenue of $2.24M (+89.8% Y/Y) misses by $0.15M.Shares +2.4% PM.Press Release For further details see: Kala Pharmaceuticals EPS misses by $0.09, misses on revenue